Back to Search
Start Over
24-Month Overall Survival from KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin with or without Pembrolizumab as First-Line Therapy forĀ Advanced Nonsquamous Non-Small Cell LungĀ Cancer.
- Source :
- Journal of Thoracic Oncology; Jan2019, Vol. 14 Issue 1, p124-129, 6p
- Publication Year :
- 2019
Details
- Language :
- English
- ISSN :
- 15560864
- Volume :
- 14
- Issue :
- 1
- Database :
- Complementary Index
- Journal :
- Journal of Thoracic Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 133664746
- Full Text :
- https://doi.org/10.1016/j.jtho.2018.08.004